Active Cancer Biomarkers Grants

PI Namesort descending Organization - Company Title Major Program / Research Group FOA
Vizio, Dolores Di Cedars-Sinai Medical Center High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Wang, Tza-Huei Jeff Johns Hopkins University A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies RFA-CA-21-004: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wang, Thomas D University Of Michigan At Ann Arbor Early detection of colorectal cancer in the traditional and serrated pathways Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Wang, Yinsheng University Of California Riverside Quantitative Adductomics Approaches for Assessing the Occurrence and Repair of DNA Adducts PAR-15-308: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Wang, Tza-Huei Johns Hopkins University Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women PA-20-185: NIH Research Project Grant
Wei, Chia-Lin Jackson Laboratory Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wei, Lei Roswell Park Cancer Institute Corp Advancing skin cancer prevention by tackling UV-induced clonogenic mutations PA-19-056: Research Project Grant
Weinberg, Aaron Case Western Reserve University Microfluidic intact cell platform: A novel tool for oral cancer detection PAR-19-150: Exploratory/Developmental Bioengineering Research Grants (EBRG)
Weissleder, Ralph Massachusetts General Hospital Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Wolpin, Brian Matthew Dana-Farber Cancer Inst Altered metabolism and machine learning for pancreatic cancer early detection Pancreatic Cancer Detection Consortium PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units
Wong, David T University Of California Los Angeles Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients PAR-15-095: Assay Validation For High Quality Markers For NCI-Supported Clinical Trials (UH2/UH3)
Wong, David T University Of California Los Angeles EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer Liquid Biopsy Consortium RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment
Wu, Yun State University Of New York At Buffalo Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Wu, Yun State University Of New York At Buffalo Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Innovative Technology Development for Cancer Research RFA-CA-18-002: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research
Wu, Yun State University Of New York At Buffalo Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay PA-20-185: NIH Research Project Grant

Pages